Telemetry Investments’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Telemetry Investments’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$10K	Hold	153,694	–	–	0.02%	114
2022 Q3	$9K	Hold	153,694	–	–	0.01%	146
2022 Q2	$6K	Hold	153,694	–	–	0.01%	170
2022 Q1	$36K	Buy	153,694 +15,000	+11%	+$4.78K	0.06%	130
2021 Q4	$90K	Buy	138,694 +38,669	+39%	+$26.8K	0.12%	130
2021 Q3	$66K	Buy	100,025 +15,025	+18%	+$11.2K	0.09%	142
2021 Q2	$73K	Buy	+85,000	New	+$59.1K	0.1%	117

Other funds holding BIOTW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.02B AUM 16.73% 1-Year Est. Return

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Ramius Advisors New York $90.9M AUM 7.33% 1-Year Est. Return

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

Q Global Advisors Fort Worth, Texas $104M AUM 20.91% 1-Year Est. Return